#EsteVirusLoParamosUnidos, following to the recommendations of our professionals and the Spanish Ministry of Health.

We decided to suspend our entire commercial network’s visits from 12th March onwards to minimize the risk of spreading the virus.

According to the guidelines of the health authorities, we have implemented various measures to protect our employees, including a work-from-home system, and strict protective measures for those workers whose attendance is essential.

We continue to offer the service our customers expect from us by phone, e-mail or videocall and we strive to ensure the availability of our products to uphold animal health and welfare.

Laboratorios Syva is working in close collaboration with the Spanish and autonomous health authorities to help – to the best of our ability – in the fight against the COVID-19 pandemic.

You may also be interested in

30 August, 2023

New tool for controlling erysipelas and PPV: Syvac® Ery Parvo

Because every farm is unique, it needs individualised protocols for swine erysipela and PPV control. Failing to control erysipelas and PPV throughout a sow's life can lead to a host of problems that are difficult to control and have a direct impact on production.

Read more

19 July, 2023

Interview with Inés Ruedas, winner of the Syva Award 2023 – Tierras Porcino

We could not miss this excellent interview, conducted by Interempresas for Tierras Porcino, which recently interviewed our Syva 2022 award winner, Inés Ruedas Torres, about her thesis and the numerous challenges that the pig sector faces in the fight against PRRSV. In her interview, Inés speaks about the new advances in the fight against this disease, but also about the...

Read more

2 March, 2023

SYVA announces its partnership with the biotech SMIVET for the development of SDA [SDA]

León - Technology Park – Spain, March 2, 2023 - SYVA and SMIVET signed a collaboration agreement that allow both companies to develop therapeutic solutions based on Single Domain Antibodies (SDA). With this agreement, Syva expresses its willingness to invest in new biotechnologies with the objective to continue to grow and improve its attractiveness by researching, developing, and producing...

Read more